Bayer AG (BAYRY)
10.19
+0.04
(+0.39%)
USD |
OTCM |
Jun 09, 16:00
Bayer EPS Diluted (Quarterly) : 0.8226 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.8226 |
| December 31, 2025 | -1.113 |
| September 30, 2025 | -0.2864 |
| June 30, 2025 | -0.0574 |
| March 31, 2025 | 0.3479 |
| December 31, 2024 | -0.0909 |
| September 30, 2024 | -1.169 |
| June 30, 2024 | -0.0093 |
| March 31, 2024 | 0.5524 |
| December 31, 2023 | 0.3659 |
| September 30, 2023 | -1.265 |
| June 30, 2023 | -0.5226 |
| March 31, 2023 | 0.5947 |
| December 31, 2022 | 0.1586 |
| September 30, 2022 | 0.1399 |
| June 30, 2022 | -0.0807 |
| March 31, 2022 | 0.9395 |
| December 31, 2021 | 0.3377 |
| September 30, 2021 | 0.0255 |
| June 30, 2021 | -0.7158 |
| March 31, 2021 | 0.6403 |
| December 31, 2020 | 0.0934 |
| September 30, 2020 | -0.8161 |
| June 30, 2020 | -2.676 |
| March 31, 2020 | 0.4174 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.3985 |
| September 30, 2019 | 0.2931 |
| June 30, 2019 | 0.1156 |
| March 31, 2019 | 0.3594 |
| December 31, 2018 | -1.200 |
| September 30, 2018 | 0.8517 |
| June 30, 2018 | 0.2583 |
| March 31, 2018 | 0.6773 |
| December 31, 2017 | 0.0492 |
| September 30, 2017 | 1.286 |
| June 30, 2017 | 0.3736 |
| March 31, 2017 | 0.6267 |
| December 31, 2016 | 0.1415 |
| September 30, 2016 | 0.3941 |
| June 30, 2016 | 0.464 |
| March 31, 2016 | 0.4964 |
| December 31, 2015 | 0.1993 |
| September 30, 2015 | 0.3309 |
| June 30, 2015 | 0.3828 |
| March 31, 2015 | 0.4462 |
| December 31, 2014 | 0.083 |
| September 30, 2014 | 0.3261 |
| June 30, 2014 | 0.388 |
| March 31, 2014 | 0.5794 |
| December 31, 2013 | 0.1842 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SenesTech, Inc. | -0.3919 |
| Dermapharm Holding SE | 0.9822 |
| Johnson & Johnson | 2.141 |
| Pfizer Inc. | 0.4688 |
| AstraZeneca PLC | 0.9849 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.237B |
| Revenue (Quarterly) | 15.68B |
| Total Expenses (Quarterly) | 12.45B |
| Enterprise Value | 78.38B |
| Gross Profit Margin (Quarterly) | 60.97% |
| Profit Margin (Quarterly) | 20.64% |
| Earnings Yield | -6.22% |
| Operating Earnings Yield | 20.16% |
| Normalized Earnings Yield | 5.280 |